Francis J. Doyle III, the dean at Harvard University’s faculty of engineering, will be on campus this Thursday, September 15 as a guest of the Department of Chemical Engineering for its David W. Bacon Distinguished Seminar Series.

On the topic “Translating Control Technology for Personalized Medicine,” Doyle promises a discussion on his work specifically regarding insulin delivery for individuals with Type 1 diabetes mellitus (T1DM).

“Over the last 5 years, multiple commercial closed-loop devices have entered the market, thus delivering the so-called ‘artificial pancreas’ to individuals with T1DM,” he says in the abstract for this presentation. “In this talk, I will outline the difficulties inherent in controlling physiological variables, the challenges with regulatory approval of such devices, and will describe several control systems engineering algorithms we have tested in clinical and outpatient settings for the artificial pancreas. I will describe our work in creating an embedded version of our MPC algorithm to enable a portable implementation in a medical IoT framework and will highlight some of the open challenges for automated insulin delivery.”

The event will take place at 2:30pm in the Rose Event Commons at Mitchell Hall, East Wing, Room 103. RSVP required. Contact April Hiles ( for further info.


Social media graphic via The Harvard Gazette